Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al

oleh: Pingfu Fu, Mohammadhadi Khorrami, Anant Madabhushi, Nathan Pennell, Khalid Jazieh, Vidya Sankar Viswanathan

Format: Article
Diterbitkan: BMJ Publishing Group 2022-05-01

Deskripsi

No description available for this item.